Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

Circulation

Volumn 105, Issue 25, 2002, Pages 3017-3024

  Walter, Dirk H ^a   Rittig, Kilian ^a   Bahlmann, Ferdinand H ^a   Kirchmair, Rudolf ^a   Silver, Marcy ^a   Murayama, Toshinori ^a   Nishimura, Hiromi ^a   Losordo, Douglas W ^a   Asahara, Takayuki ^a   Isner, Jeffrey M ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Cells; Coronary disease; Endothelium; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; ENDOTHELIUM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BONE MARROW TRANSPLANTATION; CAROTID STENOSIS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTEGRINS; KINETICS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

EID: 0037173080     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000018166.84319.55     Document Type: Article

References (34)

1. Statin trials and goals of cholesterol-lowering therapy
2. Current perspectives on statins
3. Stimulation of bone formation in vitro and in rodents by statins
4. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury
5. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
6. Effect of statin therapy on restenosis after coronary stent implantation
7. Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin
8. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
9. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease
10. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
11. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
12. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor arguments revascularization in a rabbit ischemic hind limb model
13. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer
14. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
15. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening
16. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries
17. Isolation of putative progenitor endothelial cells for angiogenesis
18. Evidence for circulating bone marrowderived endothelial cells
19. Circulating endothelial progenitor cells in peripheral blood incorporate into re-endothelialization after vascular injury
20. HMG-CoA reductase inhibitor mobilizes bone-marrow derived endothelial progenitor cells
21. HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the PI3 kinase/Akt pathway
22. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
23. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
24. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
25. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
26. Definition of two angiogenic pathways by distinct alpha v integrins
27. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
28. Mechanisms of angiogenesis and arteriogenesis
29. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects
30. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: Requirement for Flk-I/KDR activation
31. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
32. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
33. Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries
34. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development